Bibliography for: "Cumulative irritation potential of metronidazole gel compared to azelaic acid gel after repeated applications to healthy skin"

Kristin Ziel "Cumulative irritation potential of metronidazole gel compared to azelaic acid gel after repeated applications to healthy skin". Journal of Drugs in Dermatology. FindArticles.com. 20 Dec, 2009. http://findarticles.com/p/articles/mi_m0PDG/is_6_4/ai_n15882145/

Journal of Drugs in Dermatology

View more issues:

Articles in Nov-Dec, 2005 issue of Journal of Drugs in Dermatology

• Cystic acne improved by photodynamic therapy with short-contact 5-aminolevulinic acid and sequential combination of intense pulsed light and blue light activation
  by Stuart Melnick
• COL-3 demonstrates promising results for treating rosacea
• Bioengineered skin and wound healing
• Etanercept for treatment of hidradenitis
• Cumulative irritation potential of metronidazole gel compared to azelaic acid gel after repeated applications to healthy skin
  by Kristin Ziel
• Low-dose dapsone in chronic idiopathic urticaria: preliminary results of an open study
• Phase I study of Staphylococcus aureus Type 336 vaccine
• Study to determine the safety of two applications of PEP005 topical gel to nodular basal cell carcinoma
• To study the use of humanized CD25 in preventing the relapse of psoriasis vulgaris
• Evidence based or theoretical concern? Pseudotumor cerebri and depression as acitretin side effects
  by John Starling, III
• Treatment of erythematotelangiectactic rosacea with a KTP YAG laser
  by Amy Miller
• Synera topical anesthesia approved by FDA
• Survivin peptide vaccination for patients with advanced melanoma, pancreatic, colon and cervical cancer
• Prophylaxis for and treatment of uncomplicated skin and skin structure infections in laser and cosmetic surgery
  by Mark S. Nestor
• Aczone approved for acne
• Open-label assessment of the efficacy & safety of efalizumab in the treatment of mod-severe hidradenitis suppurativa
• Study of ONTAK in previously treated Cutaneous T-cell Lymphoma patients
• Safety and efficacy of alefacept in elderly patients and other special populations
  by Alice B. Gottlieb
• Q-switched Alexandrite laser-assisted treatment of melasma: 2-year follow-up monitoring
  by Antonio Rusciani
• Schools of Pharmacology
  by Noah Scheinfeld
• To study the effects of CD25 and low dose Cyclosporin in the treatment of active psoriasis vulgaris
• Perioperative use of antibiotics: preventing and treating perioperative infections
  by Mark S. Nestor
• Imiquimod as an antiangiogenic agent
  by Vincent W. Li
• Trichophyton tonsurans associated tinea corporis infection with the development of Majocchi's granuloma in a renal transplant patient
  by Vidya Rajpara
• Metronidazole 1% Topical Gel approved for rosacea
• Topical NF-kappa B Decoy in the treatment of atopic dermatitis
• Treatment of uncomplicated skin and skin infections in the pediatric and adolescent patient populations
  by Lawrence A. Schachner
• A letter from the Editor-in-Chief
  by Perry Robins
• Tolerance to calcitriol and tacalcitol in three patients with allergic contact dermatitis to calcipotriol
  by Foti Caterina
• FDA approves generic Ultravate
• Generic Locoid approved by FDA
• Five-year safety study of pimecrolimus cream 1% in infants 3 to less than 12 months of age with mild to moderate atopic dermatitis
• Optimal antibacterial treatment of uncomplicated skin and skin structure infections: applying a novel treatment algorithm
  by Dirk M. Elston
• Elidel-study
• Generic Allegra 60 mg gains FDA approval
• Pimecrolimus Cream 1% plus topical corticosteroid in patients with severe atopic dermatitis
• The effect of Efudex treatment on photoaged skin
• CollaGenex files New Drug Application for Oracea
• Temozolomide vs. dacarbazine in stage IV metastatic melanoma
• Factors affecting prescription of ultra-high potency topical corticosteroids in skin disease: an analysis of US national practice data
  by Rajesh Balkrishnan
• Orlando Dermatology & Aesthetic Conference
• Avelox IV approved for complicated skin and skin structure infections
• Treatment of uncomplicated skin and skin structure infections in the diabetic patient
  by Phoebe Rich
• Puerto Rico psoriasis study group: efficacy and safety of etanercept
  by Jose R. Gonzalez-Chavez
• Open-label pilot study of alitretinoin gel 0.1% in the treatment of photoaging
• Imatinib in dermatofibrosarcoma protuberans
• Utilization of narrow band ultraviolet B light therapy and etanercept for the treatment of psoriasis
• Nodular melanoma: how current approaches to early detection are failing
  by John W. Kelly
• Dermatofibrosarcoma protuberans following tanning bed use
  by Daniel S. Behroozan
• A randomized placebo-controlled double-blind study of levamisole in the treatment of limited and slowly spreading vitiligo
• FDA approves iPLEDGE for isotretinoin
• Efficacy of Elidel cream on erosive oral lichen planus
• Update on treating uncomplicated skin and skin structure infections
  by Theodore Rosen
• ABthrax Phase I clinical trial promising
• MediGene announces Phase 2 trial results of Polyphenon E for treatment of actinic keratosis
• Hydroxychloroquine vs. clobetasol rinse to treat oral lichen planus
• A study of the use of methotrexate in the treatment of chronic idiopathic urticaria
• Anti-CD20 monoclonal antibody in the treatment of pemphigus
• Introduction
• Bullous pemphigoid following therapy with an oral beta-blocker
  by Adam Perry
• The efficacy and safety of adapalene gel 0.3% in the treatment of acne vulgaris: a randomized, multicenter, investigator-blinded, controlled comparison study versus adapalene gel 0.1% and vehicle
• Early topical nail fungus treatment promising
• Study to determine the safety of two applications of PEP005 topical gel to superficial basal cell carcinoma
• Study of ONTAK in cutaneous T-cell lymphoma patients
• Importance of understanding pharmacokinetic/pharmacodynamic principles in the emergence of resistances, including community-associated Staphylococcus aureus
  by Thomas R. Fritsche